VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
DNTH
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
DNTHDianthus Therapeutics, Inc.
$88.21$3.7B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksDNTHQuarterly Financials

Dianthus Therapeutics, Inc. (DNTH) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Dianthus Therapeutics, Inc. (DNTH) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

DNTH Income Statement

Quarterly statement

DNTH Income Statement

Dianthus Therapeutics, Inc. (DNTH) annual income statement — 10-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Sales/Revenue761K463K284K396K193K1.16M1.33M2.17M1.86M874K457K924K969K476K1.18M1.17M0000
Revenue Growth %294.3%-60.19%-78.58%-81.77%-89.64%33.07%190.15%135.06%92.26%83.61%-61.11%-21.23%--------
Cost of Goods Sold076K00000000019K84K049K01.2M1.21M535K532K
COGS % of Revenue-16.41%---------2.06%8.67%-4.17%-----
Gross Profit761K387K284K396K193K1.16M1.33M2.17M1.86M874K457K905K885K476K1.13M1.17M-1.2M-1.21M-535K-532K
Gross Margin %100%83.59%100%100%100%100%100%100%100%100%100%97.94%91.33%100%95.83%100%----
Gross Profit Growth %294.3%-66.72%-78.58%-81.77%-89.64%33.07%190.15%140%110.51%83.61%-59.41%-22.85%174%139.34%310.47%320.49%-149.69%---
Operating Expenses62.24M46.92M69.83M40.68M35.12M34.34M33.24M32.07M24.07M18.72M13.41M16.66M12.66M8.16M11.82M9.43M16.89M22.62M19.61M17.71M
OpEx % of Revenue8179.11%10133.91%24586.27%10273.74%18196.89%2952.71%2506.94%1476.61%1291.84%2141.65%2935.01%1803.46%1306.6%1714.08%1005.87%803.67%----
Selling, General & Admin13.56M12.47M9.93M8.2M8.87M7.34M6.83M6.53M6M5.64M4.63M8.7M2.41M2.31M1.99M2.21M6.48M7.29M7.03M7.45M
SG&A % of Revenue1781.47%2692.87%3496.48%2069.44%4595.34%630.87%515.01%300.55%321.9%645.31%1013.57%941.99%248.5%485.71%169.19%188.32%----
Research & Development48.69M34.53M59.9M32.49M26.25M27M26.41M25.54M18.07M13.08M8.78M7.96M10.25M5.85M9.83M7.22M10.41M15.34M12.58M10.26M
R&D % of Revenue6397.63%7457.45%21089.79%8204.29%13601.55%2321.84%1991.93%1176.06%969.94%1496.34%1921.44%861.47%1058.1%1228.36%836.68%615.35%----
Other Operating Expenses00000000000000000000
Operating Income-61.48M-46.53M-69.54M-40.29M-34.93M-33.18M-31.92M-29.9M-22.2M-17.84M-12.96M-15.76M-11.78M-7.68M-10.69M-8.25M-18.08M-23.83M-20.14M-18.25M
Operating Margin %-8079.11%-10050.32%-24486.27%-10173.74%-18096.89%-2852.71%-2406.94%-1376.61%-1191.84%-2041.65%-2835.01%-1705.52%-1215.27%-1614.08%-910.04%-703.67%----
Operating Income Growth %-76.03%-40.26%-117.89%-34.74%-57.3%-85.93%-146.34%-89.73%-88.55%-132.25%-21.16%-90.93%34.88%67.76%46.91%54.76%-2.69%-27.47%-5.64%0.74%
EBITDA-61.45M-46.46M-69.28M-40.26M-34.83M-33.04M-31.84M-29.78M-22.09M-17.74M-12.85M-15.74M-11.69M-7.67M-10.64M-8.24M-16.89M-22.62M-19.61M-17.71M
EBITDA Margin %-8074.24%-10033.91%-24395.07%-10166.92%-18045.6%-2841.27%-2401.06%-1371.27%-1185.88%-2029.4%-2812.47%-1703.46%-1206.6%-1611.13%-905.87%-702.81%----
EBITDA Growth %-76.42%-40.59%-117.61%-35.18%-57.64%-86.3%-147.71%-89.22%-88.96%-131.28%-20.75%-90.93%30.76%66.1%45.71%53.46%1.42%-24.15%-5.57%0.97%
D&A (Non-Cash Add-back)37K76K259K27K99K133K78K116K111K107K103K19K84K14K49K10K1.2M1.21M535K532K
EBIT-50.22M-40.83M97.91M-36.77M-31.63M-29.51M-28.44M-25.17M-17.61M-13.75M-12.96M-14.76M-13.06M-7.68M-10.12M-8.25M-17.27M-22.95M-19.29M-17.43M
Net Interest Income11.54M6.26M5.27M3.66M3.4M3.79M3.99M4.45M4.71M4.22M2.44M1.03M687K606K640K416K0884K0100K
Interest Income11.54M6.26M5.27M3.66M3.4M3.79M3.99M4.45M4.71M4.22M2.44M1.03M687K606K640K416K812K884K0100K
Interest Expense0000000000000000812K000
Other Income/Expense11.27M5.7M167.45M3.52M3.3M3.67M3.48M4.73M4.6M4.1M2.39M996K636K594K577K470K812K884K848K818K
Pretax Income-50.22M-40.83M97.91M-36.77M-31.63M-29.51M-28.44M-25.17M-17.61M-13.75M-10.56M-14.76M-11.14M-7.09M-10.12M-7.78M-17.27M-22.95M-19.29M-17.43M
Pretax Margin %-6598.55%-8819.44%34473.59%-9284.09%-16388.08%-2537.49%-2144.8%-1159.02%-945.09%-1573%-2311.38%-1597.73%-1149.64%-1489.29%-860.94%-663.6%----
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-50.22M-40.83M97.91M-36.77M-31.63M-29.51M-28.44M-25.17M-17.61M-13.75M-10.56M-14.76M-11.14M-7.09M-10.12M-7.78M-17.27M-22.95M-19.29M-17.43M
Net Margin %-6598.55%-8819.44%34473.59%-9284.09%-16388.08%-2537.49%-2144.8%-1159.02%-945.09%-1573%-2311.38%-1597.73%-1149.64%-1489.29%-860.94%-663.6%----
Net Income Growth %-58.76%-38.37%444.25%-46.04%-79.64%-114.66%-169.24%-70.52%-58.05%-93.93%-4.42%-89.66%35.5%69.11%47.56%55.33%-2.03%-31.23%-6.19%1.42%
Net Income (Continuing)-50.22M-40.83M97.91M-36.77M-31.63M-29.51M-28.44M-25.17M-17.61M-13.75M-10.56M-14.76M-11.14M-7.09M-10.12M-7.78M-17.27M-22.95M-19.29M-17.43M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.90-0.852.59-0.97-0.88-0.82-0.81-0.74-0.51-0.54-2.33-3.78-0.87-7.70-2.67-2.10-4.70-6.25-5.25-4.76
EPS Growth %-2.27%-3.66%419.75%-31.08%-72.55%-51.85%65.24%80.42%41.38%92.99%12.73%-79.94%81.49%-23.3%49.15%55.88%6.81%-8.42%12.34%18.78%
EPS (Basic)-0.90-0.852.59-0.97-0.88-0.82-0.81-0.74-0.51-0.54-2.33-3.78-0.87-7.70-2.67-2.10-4.70-6.25-5.25-4.76
Diluted Shares Outstanding56.03M48.03M37.79M37.79M35.82M35.79M35.03M34.24M34.23M25.67M4.53M3.91M3.79M3.79M3.79M3.7M3.68M3.67M3.67M3.66M
Basic Shares Outstanding56.03M48.03M37.79M37.79M35.82M35.79M35.03M34.24M34.23M25.67M4.53M3.91M3.79M3.79M3.79M3.7M3.68M3.67M3.67M3.66M
Dividend Payout Ratio--------------------